Zacks has lowered its rating of AmSurg stock from "buy" to "hold," according to The Legacy.
AmSurg stock has a 52-week low of $45.19 and a 52-week high of $72.85. AmSurg has a market cap of $3.36 billion, according to the report.
Zacks rates AmSurg stock a 'hold'
Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.